People · Operator
Named in public records as an officer, director or promoter · active 2017–2023 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioventrix Inc | — | Other | Series B | $191.3M | $20.8M | 2020 |
| Pharm, LLC | — | Other | Series A | $23.2M | $107.4M | 2017 |
| Hancock Jaffe Laboratories, Inc. | — | Biotechnology | Seed | $6.8M | $67.0M | 2017 |
WILLIAM ABBOTT at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside WILLIAM ABBOTT on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Anderson | 1 | 24 |
| BIHUA CHEN | 1 | 14 |
| Kenneth Miller | 1 | 8 |
| Michael Taglich | 1 | 7 |
| Robert Doyle | 1 | 6 |
| Arthur Bertolero | 1 | 5 |
| Randy Smith | 1 | 5 |
| Ken Miller | 1 | 5 |
| Michael Wang | 1 | 4 |
| George Fazio | 1 | 3 |
| Robert Taglich | 1 | 3 |
| Steven Healy | 1 | 3 |
| DAVID RICHMOND | 1 | 2 |
| Rinda Sama | 1 | 2 |
| JAMES DILLON | 1 | 2 |
| Brent Cox | 1 | 2 |
| Heather Molloy | 1 | 2 |
| William Abraham | 1 | 2 |
| Raymond Cohen | 1 | 2 |
| Christopher Wolff | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.